Gian Marco De Marchis

Prof. Dr. med.
Gian Marco De Marchis

Position(s)
Head of Emergency Neurology Team
Deputy Head Stroke Unit, Neurology & Stroke Center
Attending Physician, Neurology & Stroke Center

Institution
University Hospital Basel

Phone +41 61 328 73 02

Email

 

Research Focus

Neurology

Area of Research

Acute cerebrovascular diseases and their management with focus on endovascular treatment and intravenous thrombolysis. Secondary Prevention of Stroke: randomized clinical trials, dyslipidemia, ideal time to start anticoagulant therapy after a stroke. Cohort studies on novel blood markers. Copeptin as first blood marker for prognosis after stroke and TIA. Prehospital stroke care networks to reduce delays. Safety and effectiveness of fast-track vs. open-end hospitalizations.


Approved Research Projects

  • AtheroGEnic LipoprotEinS in Ischemic Stroke - The AGELESS Study (Sponsor: Schweizerischer Nationalfond)
  • Serum Neurofilaments Light Chain in Acute Ischemic Stroke and Transient Ischemic Attack (cohort study).
  • Endovascular Treatment versus Best Medical Treatment for Ischemic Stroke with Large Vessel Occlusion in the 6–24 Hour Window among Non- DAWN-Non-DEFUSE Patients (Study based on the Swiss Stroke Registry)
  • Apolipoprotein (B) and Lipoprotein(a) in Patients with Acute Ischemic Stroke 

Collaborations

National Collaborations

  • Biomarker Signature of Stroke Aetiology Study: The BIOSIGNAL-Study (NCT02274727)
  • Midregion Proatrial Natriuretic Peptide to Guide Secondary Stroke Prevention (ongoing, steering committee member, NCT03961334)
  • Early versus Late initiation of direct oral Anticoagulants in post-ischaemic stroke patients with atrial fibrillatioN (ELAN, NCT03148457)
  • Swiss Atrial Fibrillation Cohort (SWISS AF)

International Collaborations

  • Tenecteplase in Wake-Up Stroke Trial (ongoing, steering committee member, NCT03181360)
  • PACIFIC-STROKE (ongoing, steering committee member, NCT04304508)

Ongoing Research Projects

  • AtheroGEnic LipoprotEinS in Ischemic Stroke - The AGELESS Study (Sponsor: Schweizerischer Nationalfond)
  • Endovascular Treatment versus Best Medical Treatment for Ischemic Stroke with Large Vessel Occlusion in the 6–24 Hour Window among Non- DAWN-Non-DEFUSE Patients (Study based on the Swiss Stroke Registry)
  • Apolipoprotein (B) and Lipoprotein(a) in Patients with Acute Ischemic Stroke 

Research Team

Tolga Dittrich
Dr. med. Tolga Daniel Dittrich

PhD Student

Phone +41 61 328 63 86
Email

DeMarchis
Mara Aujesky

Research fellow

Phone +41 79 951 91 22
Email

Liliane Kriemler
Liliane Kriemler, BSc

Doctoral student

Phone +41 61 265 35 64
Email

Salome Rudin
Salome Rudin

Doctoral student

Phone +41 61 556 51 23
Email